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Abstract: In the present article, we describe a study of antitumor activity in breast cell lines 
using silver nanoparticles (Ag NPs) synthesized by a microbiological method. These Ag NPs 
were tested for their antitumor activity against MCF7 and T47D cancer cells and MCF10-A 
normal breast cell line. We analyzed cell viability, apoptosis induction, and endocytosis activity 
of those cell lines and we observed that the effects of the biosynthesized Ag NPs were directly 
related with the endocytosis activity. Moreover, Ag NPs had higher inhibition efficacy in tumor 
lines than in normal lines of breast cells, which is due to the higher endocytic activity of tumor 
cells compared to normal cells. In this way, we demonstrate that biosynthesized Ag NPs can 
be an alternative for the treatment of tumors.
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Introduction
Breast cancer is the most frequently diagnosed malignancy in women.1 Despite 
considerable advances in early detection, diagnosis, and treatment, breast cancer is 
among the leading causes of cancer-related death in women.2
Silver nanoparticles (Ag NPs) have gained interest in the field of nanomedicine due 
to their unique properties and obvious therapeutic potential in the diagnosis and treatment 
of some human cancer types.3 Numerous studies have used Ag NPs to induce apoptosis 
in tumor cell lines, but so far, no study has been able to reliably observe a significant 
difference in the effect of the Ag NPs between tumor and nontumor cell lines.4–6
The Ag NPs can be synthesized by chemical or microbiological methods. During 
the past few years, the microbiological alternative has gained importance because it 
presents some important advantages over chemical synthesis such as higher production, 
faster production, lower costs, and being eco-friendly.7–19 Other relevant advantages 
have been observed in the different functional groups conjugated with the surface of 
biosynthesized Ag NPs, which could play an important role in various biomedical 
applications.5,16
In the search for specific mechanisms which focus on discriminating tumor and 
nontumor cells, recent studies have reported that the endocytosis activity of tumor cells 
is largely increased compared to nontumor cells.20 Considering that the mechanism by 
which Ag NPs are uptaken by cells may be endocytosis,21,22 and due to endocytosis being 
increased in tumor cells, we hypothesized that Ag NPs produced by microbiological 
methods will be uptaken in a higher proportion by tumor cells than nontumor cells and 
will therefore be capable of inducing higher apoptosis rates in those cells.
In the present work, Ag NPs synthesized by a microbiological method were tested 
as antitumoral agents using two breast cancer cell lines. Fluorescent microscopy was 
Correspondence: José A lorente
geNyo, Centre for genomics and 
Oncological Research, Pfizer-University 
of granada , Andalusian Regional 
government, PtS granada, Avenida de 
Ilustración, 114 18016 granada, Spain
email jose.lorente@genyo.es
Journal name: International Journal of Nanomedicine
Article Designation: Methodology
Year: 2015
Volume: 10
Running head verso: Ortega et al
Running head recto: Antitumor activity using silver nanoparticles produced by yeast
DOI: http://dx.doi.org/10.2147/IJN.S75835
International Journal of Nanomedicine 2015:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2022
ortega et al
used to measure endocytosis, showing the differences in 
apoptosis rates and cell viability between tumor and non-
tumor cells.20
Materials and methods
Silver nanoparticles
The Ag NPs used in the present study were synthesized and 
characterized in the Laboratory of Industrial Microbiology 
of FQByF (Universidad Nacional de San Luis, [UNSL]) 
(unpublished data). These nanoparticles were obtained 
by microbiological synthesis from culture supernatants of 
the yeast Cryptococcus laurentii (BNM 0525). Moreover, 
chemical Ag NPs from Sigma-Aldrich Co. (St Louis, MO, 
USA) were used as control. The principal characteristics of 
Ag NPs are presented in Table 1.
Cell culture
MCF7 and T47D human breast cancer cells and MCF10-A 
normal breast cells were kindly provided by Scientific 
Implementation Center, University of Granada, Granada, 
Spain. Breast cancer cell lines were grown adherently and 
maintained in Dulbecco’s Modified Eagle’s Medium con-
taining 10% fetal bovine serum, and 1% antibiotic solution 
containing penicillin and streptomycin at 37°C in 5% CO
2
. 
MCF10-A line cells were grown adherently and maintained 
in Mammary Epithelial Cell Growth Medium (without fetal 
bovine serum), 1% antibiotic solution containing penicillin 
and streptomycin, and 100 ng⋅mL-1 of choleric toxin, which 
has an enhanced mitogenic effect on epithelial cells.23 All 
experiments were performed in six-well plates, unless stated 
otherwise. Cells were seeded onto the plates at a density of 
1×106 cells per well and incubated for 24 hours prior to the 
experiments. 
Cell viability assay
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide) assay is a colorimetric assay for assessing 
cell viability. The NAD(P)H oxidoreductase enzymes may 
reflect the number of viable cells present. These enzymes 
are capable of reducing the tetrazolium dye MTT to purple 
insoluble formazan.24 MTT assay was used to determine 
cellular mitochondrial dehydrogenase activity, in order to 
reflect cell death.
The cells were plated in 96-well plates at an initial density 
of 1×104 cells per well and cultured for 12 hours. Following 
this, different concentrations of Ag NPs were added and 
incubated for another 12 hours. Then, a total of 50 μL of MTT 
solution 2 mg⋅mL-1 in phosphate buffered saline (PBS) was 
added to each well and incubated for 4 hours. After careful 
removal of the culture media, 150 μL dimethyl sulfoxide per 
well was added to dissolve the precipitate for 30 minutes. 
Plates were read on a microplate reader (NanoQuant, Infinite 
M200 pro; Tecan, San Jose, CA, USA) at a wavelength of 
570 nm and a reference wavelength of 690 nm.
Annexin assay
Annexin A5 is used as a test to detect phosphatidylserine 
and phosphatidylethanolamine expression on cell surface, 
an event found in apoptosis as well as other forms of cell 
death.25–27 The three cell lines were incubated for 12 hours 
with 0, 2.5, and 5 μg⋅mL-1 of Ag NPs. After that, the cells 
were unstuck with trypsin and apoptosis detection was 
made using the Annexin V-FITC Apoptosis Detection Kit 
(Abcam, Cambridge, UK). Cells were labeled with annexin 
V fluorescein isothiocyanate (FITC) and counted by flow 
cytometry (Becton, Dickinson and Company, Franklin 
Lakes, NJ, USA).
Western blotting
To determine procaspase-9 and Bcl-2, the culture cells were 
exposed to 5 μg⋅mL-1 of Ag NPs. Cells were collected at 
12 hours and lysed with buffer lysis (Cell Signaling Tech-
nology, Boston, MA, USA). Proteins were extracted and 
quantified by Pierce® BCA-Protein assay kit (Thermo Fisher 
Scientific, Waltham, MA, USA) and 20 μg of proteins per 
well were placed in polyacrylamide gel (Bio-Rad Laborato-
ries Inc., Hercules, CA, USA) and transferred to membrane 
(Bio-Rad Laboratories Inc.) by fast transference trans blot® 
Turbo (Bio-Rad Laboratories Inc.). Membranes were blocked 
with nonfat milk for 1 hour and incubated with their cor-
responding primary antibodies overnight. Then, membranes 
were cleaned in PBS Tween 0.2% and incubated with corre-
sponding secondary antibodies conjugated with horseradish 
peroxidase for 1 hour. After the cleaning of the membranes, 
they were revealed (GE Healthcare Ltd, Little Chalfont, UK) 
and observed in the photocamera (ImageQuant LAS 4000; 
GE Healthcare).
Table 1 Principal characteristics of used Ag NPs of different origins
Origin aSize (nm) bFunctional groups conjugated 
with the surface of Ag NPs
Chemical 30±10 None
Cryptococcus laurentii 35±10 –oh, –Nh–, aliphatic Ch, 
C=o, CN, CC, C-oh, C-o-C
Notes: atransmission electron microscopy; bFourier transformed infrared chara-
cteri zations.
Abbreviation: Ag NPs, silver nanoparticles.
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Caspase-3/7 and -8 activities
Caspase-3/7 and -8 activities were measured using 
Caspase-Glo® 3/7 and Caspase-Glo® 8 Assay kits 
( Promega  Corporation, Fitchburg, WI, USA) according to 
manufacturer’s instructions. (Caspase-Glo® 3/7 kit use a 
substrate to caspase-3 and caspase-7, detect activity of each 
one is not possible) Briefly, MCF7, T47D, and MCF10-A 
cells were seeded at 5×104 cells/well in 96-well plates and 
grown for 12 hours. After incubation for 6 hours with 0, 
2.5, and 5 μg⋅mL-1 of Ag NPs, Caspase-Glo® reagent was 
added in each well. These plates were incubated for 1 hour, 
and the luminescence was determined by luminometer. 
We present the data as the mean ± standard deviation from 
three replicates.
FItC-dextran assay
Endocytosis differences between MCF7, T47D, and 
MCF10-A cell lines were measured using FITC-dextran 
(FD10S, average molar weight: 10.000; Sigma-Aldrich Co.). 
Cells were grown in 24-well plates over poly-l-lysine-coated 
coverslips for 12 hours, then treated with FITC-dextran 
at 0.5 mg⋅mL-1 and incubated for 0, 6, and 12 hours in 
culture conditions. After washing with cold PBS and fixing 
with 4% paraformaldehyde, the coverslips were mounted 
onto slides, using mounting medium with 4′,6-diamidino-
2-phenylindole (DAPI). The samples were analyzed by 
fluorescence confocal microscope and quantification was 
performed using ImageJ 1.47t software (National institutes 
of Health, Bethesda, MD, USA).
Ag NPs endocytosis
To check that the Ag NPs are endocyted by the cells, 
a FITC conjugation was realized thanks to NH
2
 groups 
associated to NPs. (Figure S1). On milliliter of the Ag 
NPs suspension was added to a solution of FITC in 
0.1 M carbonate–bicarbonate buffer and vortexed for 
1 minute, and the vial reaction was covered with alumi-
num foil and incubated for 2 hours at room temperature. 
To finish, the Ag NPs were washed with cold PBS. The 
cell lines were incubated with conjugated FITC Ag NPs 
for 15 minutes. After the incubation, the cells were 
washed with cold PBS and fixed as described previously, 
followed by a fluorescent identification of the early 
endosome marker EEA1. The cells were incubated for 
30 minutes with blocking reagent, then incubated over-
night with anti-EEA1 antibody (Abcam), and finally 
for 1 hour with alexa fluor 568 conjugated secondary 
antibody (Figure S2). The slides were mounted using 
mounting medium with DAPI (Vector, Cambridgeshire, 
UK). Finally, the analysis was performed with confocal 
microscope (Zeiss LSM710; Carl Zeiss Meditec AG, 
Jena, Germany).
endocytosis inhibition
To see if the Ag NPs endocytosis is related to the cell activ-
ity loss, we performed a comparison between treated and 
untreated cells with dynasore. Dynasore is a dynamin inhibi-
tor and dynamin is essential for clathrin-dependent coated 
vesicle formation. It is required for membrane budding at a 
late stage during the transition from a fully formed pit to a 
pinched-off vesicle.28 The cells were cultured in a 96-well 
plate for 12 hours, then they were incubated with dynasore for 
6 hours, and finally were incubated with 0, 2.5, and 5 μg⋅mL-1 
of Ag NPs for 12 hours. To detect the cell viability, an MTT 
assay was performed as described previously. 
Statistical analysis
Experiments were performed in triplicates. Data are expressed 
as mean ± standard error. Statistical analyses were performed 
using independent t-tests for two-group comparisons and a 
one-way analysis of variance, after checking homogeneity 
of variance using Levene’s test, in case of multiple com-
parisons. Analysis of variance was followed by post-hoc 
Scheffé’s test. Differences at P0.05 were considered to 
be statistically significant.
Results
Previous studies
Prior to the present work, our previous studies of antitumor 
activity using chemical Ag NPs from Sigma-Aldrich Co. 
as control were been carried out. The chemical Ag NPs 
showed antitumor activity. But these did not show significant 
differences between tumor and nontumor cells (Figure S3; 
Table S1).
Antitumoral activity
To determinate cytotoxicity of Ag NPs, MTT assays were 
carried out. We observed that cell viability reduction was 
correlated to Ag NP concentrations so that, at higher Ag NP 
concentrations, there was higher cell viability inhibition. 
A key aspect in this research was to see if tumor cells (MCF7 
and T47D) were more sensitive than nontumor cells to the 
presence of Ag NPs. Figure 1 and Table S1 show that cell 
viability was significantly reduced in tumor cells follow-
ing 12 hours’ incubation and using concentrations above 
2.5 μg⋅mL-1, while in the case of MCF10-A, cell viability 
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was just slightly reduced. Therefore, these data confirm 
that tumor cells are more sensitive than nontumor cells to 
biosynthetic Ag NPs treatment.
To see if the cell viability was reduced via apoptotic 
pathways, we performed annexin V affinity assay, which 
labels cells found in apoptosis so they can be detected by 
flow cytometry analysis. Following 6 hours’ incubation and 
using 5 μg⋅mL-1 Ag NPs, 61% and 57% of the total num-
ber of MCF7 and T47D cells were found in the apoptosis 
process, respectively, while in the case of MCF10-A, the 
apoptotic population corresponded to just approximately 
17% ( Figures 2 and S4; Table S2).
To observe if apoptosis was induced via either extrinsic 
or intrinsic pathways, as the result of mitochondrial toxicity 
generated by Ag ions inside of mitochondria,4–6 we analyzed 
caspase-9 and Bcl-2 concentrations by Western blotting, 
and caspase-8 and caspase-3/7 concentrations by luciferase 
assay from cell lysates. The results showed that caspase-9 
was overexpressed and caspase-3/7 activity was increased 
in MCF7 and T47D cells treated with Ag NPs, and those 
increases were proportional to Ag NP concentrations. 
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Figure 1 Antiproliferative efficacies of biosynthesized Ag NPs produced by 
Cryptococcus laurentii at different concentrations. 
Notes: Mtt assay was used on MCF7, t47d, and MCF10-A. All values are 
expressed as the means of the difference between optical density at 480 and 690 
nm ± standard deviation. 
Abbreviations: Ag NPs, silver nanoparticles; od, optical density; Mtt, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
100.00
90.00
80.00
70.00
60.00
50.00
40.00
30.00
20.00
10.00
0.00
0 µg·mL–1 2.5 µg·mL–1 5 µg·mL–1
P1 Annexin – P2 Annexin +
M
C
F7
M
C
F7
T4
7D
M
C
F1
0-
A
T4
7D
M
C
F7
M
C
F1
0-
A
M
C
F1
0-
A
T4
7D
Fl
ow
 c
yt
om
et
ry
Figure 2 Annexin V-FITC flow cytometry assay. 
Notes: Negative annexin V populations are presented in P1 columns while positive 
populations are presented in P2 columns. Bar chart comparing effect of 0, 2.5, and 
5 μg⋅ml-1 Ag NPs produced by Cryptococcus laurentii after 12 hours’ incubation.
Abbreviations: FITC, fluorescein isothiocyanate; Ag NPs, silver nanoparticles.
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Figure 3 Western-blot quantification of Bcl-2 and caspase-9 by ImageJ software. 
Notes: to determine relative intensity values, the maximum value for each 
protein was assigned as 100%. Caspase-8 and caspase-3/7 activities were assigned 
by chemiluminescent assay following 6 hours’ incubation with 0, 1, and 2 mg⋅ml-1 
Ag NP concentrations.
Abbreviation: Ag NPs, silver nanoparticles.
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 Moreover, Bcl-2 expression proportionally decreased as Ag 
NP concentrations increased, while caspase-8 activity was 
unaffected. On the other hand, in nontumoral MCF10-A cells, 
caspase levels and activities presented only subtle changes, 
and Bcl-2 concentration was also maintained at constant 
levels (Figures 3 and 4).
endocytosis activity
To assess endocytosis activity, we performed a FITC-dextran 
assay, where we observed that tumor cells uptake dextran 
particles faster than MCF10-A cells (Figures 5 and S5). 
When we used FITC-conjugated Ag NPs, we observed that 
the Ag NPs enter into the tumor cells through endosomes. 
The colocalization between EEA 1 and Ag NPs was observed 
in the confocal analysis (Figure 6). The inhibition of endo-
cytosis with dynasore showed an increase in cell viability 
in treated cells relative to untreated cells in the MTT assay 
results (Figure 7).
Discussion
The aim of this work was to apply Ag NPs previously 
synthesized by a microbiological method in order to assess 
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Figure 4 Caspase-8 and caspase-3/7 activities were assigned by chemiluminescent assay following 12 hours’ incubation with 0, and 5 μg⋅ml-1 Ag NP concentrations.
Abbreviation: Ag NPs, silver nanoparticles.
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Figure 5 Fluorescent microscopy images of endocytosis assay using FItC-dextran. 
Notes: MCF7, t47d, and MCF10-A incubated with FItC-dextran 10.000 kd (0.5 mg⋅ml-1) at 37°C for 0, 4, and 8 hours. Nuclear fluorescence was obtained by DAPI.
Abbreviations: dAPI, 4′,6-diamidino-2-phenylindole; FITC, fluorescein isothiocyanate.
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their cytotoxic activity and sensitivity in tumor and nontumor 
cell lines of breast cancer. 
The cytotoxicity assays of biosynthesized Ag NPs 
from culture supernatants of C. laurentii showed that these 
Nucleus DAPI
A
B
C
EEA1 Cy3 Ag NPs FITC Merge
Figure 6 Fluorescent microscopy images to identify Ag NPs and eeA1.
Notes: The colocalization between EEA1 and AgNPs was observed in the confocal analysis. The arrows show the points with colocalization. Nuclear fluorescence was 
obtained with dAPI. A and B are MCF7 cells; C are t47d cells.
Abbreviations: dAPI, 4′,6-diamidino-2-phenylindole; FITC, fluorescein isothiocyanate; Ag NPs, silver nanoparticles.
Ag NPs reduced cell viability of two cell lines related to 
breast cancer. We observed that cell viability of breast 
tumor lines MCF7 and T47D was considerably decreased 
when cells were exposed to Ag NPs at concentration levels 
from and above 2.5 μg⋅mL-1. Moreover, apoptotic assays 
demonstrated that cell viability was induced by apoptotic 
mechanisms generated through the intrinsic pathway of 
caspase activation.29
On the other hand, according to assays of the functional 
groups conjugated with the surface of Ag NPs and Fourier 
transformed infrared studies (unpublished data), we can 
confirm the presence of yeast proteins and polymeric car-
bohydrates perhaps of arabinogalactan type surrounding this 
nanoparticle, which would not allow their passing through 
cytoplasmic membranes by simple diffusion. Therefore, 
big parts of biosynthesized Ag NPs are uptaken by cells via 
endocytosis, and they enter into the cytosol within endo-
somes. These endosomes then fuse with lysosomes to give 
rise to endolysosomes characterized by an acidic environ-
ment. Then, inside the endolysosomes, the biosynthesized 
Ag NPs are catabolized forming amino acids and Ag ions.30 
These ions produce increments of reactive oxygen species 
Figure 7 Antiproliferative efficacy of biosynthesized Ag NPs produced by Crypto­
coccus laurentii at different concentrations after 12 hours. 
Notes: Mtt assay was used on dynasore treated and non-treated MCF7, t47d, 
and MCF10-A. All values are expressed as the means of the difference between 
optical density at 480 and 690 nm ± standard deviation. 
Abbreviations: Ag NPs, silver nanoparticles; od, optical density; Mtt, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
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that, at mitochondrial levels, generate a dysfunction and 
the activation of caspases involved in apoptotic intrinsic 
pathways.31
Moreover, by comparing apoptosis induction by Ag 
NPs in the MCF10-A nontumor cell line and MCF7 and 
T47D tumor cell lines, it can be clearly seen that the impact 
of biosynthesized Ag NPs from C. laurentii was signifi-
cantly lower in the nontumor cells than in the tumor cells. 
We also observed, through utilization of FITC-dextran 
endocytosis assay, that MCF10-A has a lower endocytosis 
capability than MCF7 and T47D. These differences in 
endocytic capabilities between tumor and nontumor cells 
could explain why tumor cells are induced into apoptosis 
at lower Ag NPs concentrations than nontumor cells. For 
this reason, biosynthesized Ag NPs from C. laurentii, 
which are associated with proteins, can be an alternative to 
tackle, in a selective manner, tumor cells versus nontumor 
cells where differences in endocytosis activity acts as the 
targeting mechanism.
Conclusion
In conclusion, we have shown that biosynthesized Ag 
NPs from culture supernatants of C. laurentii induce 
apoptosis in breast cancer cell lines while having a much 
milder effect in nontumor cell lines. Previous studies 
demonstrated that those Ag NPs were capped by yeast 
proteins and polymeric carbohydrates of arabinogalactan 
type, which is pivotal to avoid passive penetration through 
cytoplasmatic membranes by NPs into mammalian cells. 
Therefore, these biosynthesized Ag NPs were uptaken 
by breast cell lines via endocytosis, which is increased in 
tumor cells compared to nontumor cells. This has allowed 
us to present endocytic activity differences between tumor 
and nontumor cells as a targeting mechanism for selective 
antitumor treatments. These results can help to advance the 
design of new functionalized Ag NPs for direction towards 
specific tumor markers. 
Acknowledgments
Support from Universidad Nacional de San Luis, to the 
Agencia Nacional de Promoción Científica y Tecnológica, 
from Consejo Nacional de Investigaciones Científicas 
y Técnicas (CONICET) (Argentina), and from GENYO, 
Centre for Genomics and Oncological Research: Pfizer-
University of Granada, Andalusian Regional Government, 
Granada, Spain are acknowledged.
Disclosure
The authors report no conflicts of interest in this work.
References 
 1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer 
J Clin. 2010;60(5):277–300.
 2. Nadal R, Fernandez A, Sanchez-Rovira P, et al. Biomarkers charac-
terization of circulating tumour cells in breast cancer patients. Breast 
Cancer Res. 2012;14(3):R71.
 3. Yezhelyev MV, Gao X, Xing Y, Hajj AA, Nie S, O’Regan RM. Emerg-
ing use of nanoparticles in diagnosis and treatment of breast cancer. 
Lancet Oncol. 2006;7(8):657–667.
 4. Gurunathan S, Raman J, Abd Malek SN, John PA, Vikineswary S. Green 
synthesis of silver nanoparticles using Ganoderma neo-japonicum 
Imazeki: a potential cytotoxic agent against breast cancer cells. Int 
J Nanomedicine. 2013;8:4399–4413.
 5. Gopinath P, Gogoi SK, Sanpui P, Paul A, Chattopadhyay A, Ghosh 
SS. Signaling gene cascade in silver nanoparticle induced apoptosis. 
Colloids Surf B Biointerfaces. 2010;77(2):240–245.
 6. Hekmat A, Saboury AA, Divsalar A. The effects of silver nanoparticles 
and doxorubicin combination on DNA structure and its antiproliferative 
effect against T47D and MCF7 cell lines. J Biomed Nanotechnol. 2012; 
8(6):968–982.
 7. Blanco-Andujar C, Tung LD, Thanh NTK. Synthesis of nanoparticles 
for biomedical applications. Annual Reports Section “A” (Inorganic 
Chemistry). 2010;106:553–568.
 8. Durán N, Marcato PD, Ingle A, Gade A, Rai M. Fungi-Mediated 
Synthesis of Silver Nanoparticles: Characterization Processes and 
Applications. In: Rai M, Kövics G, editors. Progress in Mycology. 
Scientific Publishers, Jodhpur, India. 2010:425–449.
 9. Gade A, Ingle A, Whiteley C, Rai M. Mycogenic metal nanoparticles: 
progress and applications. Biotechnol Lett. 2010;32(5):593–600.
 10. Gaikwad S, Ingle A, Gade A, et al. Antiviral activity of mycosynthesized 
silver nanoparticles against herpes simplex virus and human 
parainfluenza virus type 3. Int J Nanomedicine. 2013;8:4303–4314.
 11. Marcato PD, Nakasato G, Brocchi M, et al. Biogenic silver nanopar-
ticles: antibacterial and cytotoxicity applied to textile fabrics. Journal 
of Nano Research. 2012;20:69–76.
 12. Singh R, Wagh P, Wadhwani S, et al. Synthesis, optimization, and 
characterization of silver nanoparticles from Acinetobacter calcoa-
ceticus and their enhanced antibacterial activity when combined with 
antibiotics. Int J Nanomedicine. 2013;8:4277–4290.
 13. Zhang X, Yan S, Tyagi RD, Surampalli RY. Synthesis of nanoparticles 
by microorganisms and their application in enhancing microbiological 
reaction rates. Chemosphere. 2011;82(4):489–494.
 14. Kumar RR, Priyadharsani KP, Thamaraiselvi K. Mycogenic synthesis of 
silver nanoparticles by the Japanese environmental isolate Aspergillus 
tamarii. J Nanopart Res. 2012;14:860–865.
 15. Rodriguez AG, Ping LY, Marcato PD, et al. Biogenic antimicrobial 
silver nanoparticles produced by fungi. Appl Microbiol Biotechnol. 
2013;97(2):775–782. 
 16. Durán N, Marcato PD, Durán M, Yadav A, Gade A, Rai M. Mechanistic 
aspects in the biogenic synthesis of extracellular metal nanoparticles 
by peptides, bacteria, fungi, and plants. Appl Microbiol Biotechnol. 
2011;90:1609–1624.
 17. Subramanian M, Alikunhi NM, Kandasamy K. In Vitro Synthesis of 
Silver Nanoparticles by Marine Yeasts from Coastal Mangrove Sedi-
ment. Adv Sci Lett. 2010;3(4):428–433.
 18. Mishra A, Tripathy SK, Yun SI. Bio-synthesis of gold and silver nanoparticles 
from Candida guilliermondii and their antimicrobial effect against patho-
genic bacteria. J Nanosci Nanotechnol. 2011;11(1):243–248.
 19. Namasivayam SKR, Ganesh S, Avimanyu. Evaluation of anti-bacterial 
activity of silver nanoparticles synthesized from Candida glabrata and 
Fusarium oxysporum. Int J Med Res. 2011;1(3):131–136.
 20. Levine MN, Hoang TT, Raines RT. Fluorogenic probe for constitutive 
cellular endocytosis. Chem Biol. 2013;20:614–618.
 21. dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. Quantitative 
assessment of the comparative nanoparticle-uptake efficiency of a range 
of cell lines. Small. 2011;7(23):3341–3349.
 22. Wall DA, Maack T. Endocytic uptake, transport, and catabolism of pro-
teins by epithelial cells. Am J Physiol. 1985;248(1 Pt 1):C12–C20.
International Journal of Nanomedicine 2015:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2028
ortega et al
 23. Taylor-Papadimitriou J, Purkis P, Fentiman IS. Cholera toxin and ana-
logues of cyclic AMP stimulate the growth of cultured human mammary 
epithelial cells. J Cell Physiol. 1980;102:317–321.
 24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: 
application to proliferation and cytotoxicity assays. J Immunol Methods. 
1983;65(1–2):55–63.
 25. Huber R, Berendes R, Burger A, et al. Crystal and molecular struc-
ture of human annexin V after refinement. Implication for structure, 
membrane binding and ion channel formation of the annexin family of 
proteins. J Mol Biol. 1992;223(3):683–704.
 26. Zhou T, Rosen BP. Tryptophan fluorescence reports nucleotide-induced 
conformational changes in a domain of the ArsA ATPase. J Biol Chem. 
1997;272(32):19731–19737.
 27. van Engleland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. 
Annexin V-affinity assay: a review on an apoptosis detection system based 
on phosphatidylserine exposure. Cytometry. 1998;31(1):1–9.
 28. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, 
Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev 
Cell. 2006;10(6):839–850.
 29. Hileman EO, Liu J, Albitar M, Keating MJ, Huang P. Intrinsic oxidative 
stress in cancer cells: a biochemical basis for therapeutic selectivity. 
Cancer Chemother Pharmacol. 2004;53(3):209–219. 
 30. Sundaramoorthi C, Kalaivani M, Mathews DM, Palanisamy S, 
Kalaiselvan V, Rajasekaran A. Biosynthesis of silver nanoparticles 
from Aspergillus niger and evaluation of its wound healing activity in 
experimental rat model. International Journal of PharmTech Research. 
2009;1(4):1523–1529.
 31. Vertelov GK, Krutyakov YA, Efremenkova OV, Olenin AY, 
Lisichkin GV. A versatile synthesis of highly bactericidal Myramistin® 
stabilized silver nanoparticles. Nanotechnology. 2008;19(35): 
355707.
International Journal of Nanomedicine 2015:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2029
Antitumor activity using silver nanoparticles produced by yeast
Supplementary materials
1 & 6
&22+1+ &22+
1+ 1+
$J13
$J13&
6
2 22+22+2
),7& ),7&
Figure S1 graphic representation of conjugation reaction between Ag NPs and FItC molecules.
Abbreviations: FITC, fluorescein isothiocyanate; Ag NPs, silver nanoparticles.
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Figure S2 Absorption and emission spectrums of used fluorochromes. 
Notes: dAPI: blue; FItC: green; and Alexa Fluor 568: red.
Abbreviations: dAPI, 4′,6-diamidino-2-phenylindole; FITC, fluorescein isothiocyanate.
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Figure S3 Antiproliferative efficacy of the Ag NPs produced by synthetic methods at different concentrations.
Notes: Mtt assay was used on MCF7, t47d, and MCF10-A. All values are expressed as the means of the difference between optical density at 570 and 690 nm ± standard 
deviation.
Abbreviations: Ag NPs, silver nanoparticles; od, optical density; Mtt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
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Table S1 Numeric table comparing cell viability of 0, 2.5, and 5 μg⋅ml-1 Ag NPs produced by Cryptococcus laurentii and by synthetic 
methods
0 µg/mL SD P-value 2.5 µg/mL SD P-value 5 µg/mL SD P-value
Ag NPs produced by Cryptococcus laurentii
MCF7 0.59 0.065 N/S 0.37 0.091 0.038 0.31 0.057 0.019
t47d 0.58 0.065 N/S 0.39 0.031 0.024 0.33 0.049 0.023
MCF10-A 0.55 0.048 N/S 0.54 0.081 N/S 0.51 0.094 N/S
Chemical Ag NPs
MCF7 0.56 0.071 N/S 0.31 0.091 N/S 0.20 0.074 N/S
t47d 0.57 0.063 N/S 0.37 0.068 N/S 0.22 0.056 N/S
MCF10-A 0.52 0.061 N/S 0.25 0.024 N/S 0.14 0.072 N/S
Notes: After 12 hours’ incubation. Values are expressed as the means of the difference between optical density at 570 and 690 nm; P-value is shown when the differences 
are statistically significant with respect to MCF10-A.
Abbreviations: Ag NPs, silver nanoparticles; N/S, nonsignificant; SD, standard deviation.
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Figure S4 Typical figure of flow cytometry that shows annexin V expression between MCF7, T47D, and MCF10-A cell lines.
Notes: A, B, and C show the dot plot of cytometry analysis, the population 2 (P2)  included the single epithelial cells. D, E, and F show the histogram plot of P2 that 
separates between P3 (positive annexin) and P4 (negative annexin). G, H, and I show the estatistic parameters of the three populations.
Abbreviations: FITC, fluorescein isothiocyanate; FSC-A, forward scatter area; SSC-A, side scatter area.
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Table S2 Numeric table comparing effect of 0, 2.5, and 5 μg⋅ml-1 of Ag NPs produced by Cryptococcus laurentii after 12 hours’ 
incubation
Negative and 
positive populations
0 µg⋅mL-1 2.5 µg⋅mL-1 5 µg⋅mL-1
MCF7 T47D MCF10-A MCF7 T47D MCF10-A MCF7 T47D MCF10-A
P1 92.73 92.67 91.733 64 67.2 88.5 38.633 42.7 83.066
P2 7.27 7.33 8.2666 36 32.8 11.5 61.366 57.3 16.933
Note: Negative annexin V populations are presented in P1 row while positive populations are in presented P2 row.
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Figure S5 endocytosis assay using FItC-dextran. 
Notes: Fluorescent intensity of cells was measured in eight fields per sample and is presented as mean ± standard deviation.
Abbreviation: FITC, fluorescein isothiocyanate.
